|
|
||||||||
at the Site of Infection Determines Rate of Clearance of Infection in Cryptococcal Meningitis1
,



,¶
,¶
,¶
* Departments of Infectious Diseases and Immunology, St. Georges Hospital Medical School, London, United Kingdom;
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand;
Department of Internal Medicine and Infectious Diseases, University Medical Centre, Nijmegen, The Netherlands;
London School of Hygiene and Tropical Medicine, London, United Kingdom; and
¶ Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
In animal models, immunity to cryptococcal infection, as in many chronic fungal and bacterial infections, is associated with a granulomatous inflammatory response, intact cell-mediated immunity, and a Th1 pattern of cytokine release. To examine the correlates of human immunity to cryptococcal infection in vivo, we analyzed immune parameters at the site of infection over time and assessed the rate of clearance of infection by serial quantitative cerebrospinal fluid (CSF) fungal cultures in 62 patients in a trial of antifungal therapy for HIV-associated cryptococcal meningitis. CSF IL-6, IFN-
, TNF-
, and IL-8 were significantly higher in survivors compared with nonsurvivors. There were negative correlations between log TNF-
, IFN-
, and IL-6 levels and baseline cryptococcal CFU. Log IFN-
, G-CSF, TNF-
, and IL-6 were correlated positively with the rate of fall in log CFU/ml CSF/day. In a linear regression model including antifungal treatment group, baseline CFU, and these cytokines, only treatment group and log IFN-
remained independently associated with rate of clearance of infection. The results provide direct in vivo evidence for the importance of quantitative differences in IFN-
secretion in human immune control of granulomatous infections, and increase the rationale for adjunctive IFN-
in the treatment of refractory HIV-associated cryptococcosis.
This article has been cited by other articles:
![]() |
K. Voelz, D. A. Lammas, and R. C. May Cytokine Signaling Regulates the Outcome of Intracellular Macrophage Parasitism by Cryptococcus neoformans Infect. Immun., August 1, 2009; 77(8): 3450 - 3457. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. John, A. Panoskaltsis-Mortari, R. O. Opoka, G. S. Park, P. J. Orchard, A. M. Jurek, R. Idro, J. Byarugaba, and M. J. Boivin Cerebrospinal Fluid Cytokine Levels and Cognitive Impairment in Cerebral Malaria Am J Trop Med Hyg, February 1, 2008; 78(2): 198 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Brouwer, H. J. M. van Kan, E. Johnson, A. Rajanuwong, P. Teparrukkul, V. Wuthiekanun, W. Chierakul, N. Day, and T. S. Harrison Oral versus Intravenous Flucytosine in Patients with Human Immunodeficiency Virus-Associated Cryptococcal Meningitis Antimicrob. Agents Chemother., March 1, 2007; 51(3): 1038 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Wormley Jr., J. R. Perfect, C. Steele, and G. M. Cox Protection against Cryptococcosis by Using a Murine Gamma Interferon-Producing Cryptococcus neoformans Strain Infect. Immun., March 1, 2007; 75(3): 1453 - 1462. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Barbosa, F. L. Fonseca, R. T. Figueiredo, M. T. Bozza, A. Casadevall, L. Nimrichter, and M. L. Rodrigues Binding of Glucuronoxylomannan to the CD14 Receptor in Human A549 Alveolar Cells Induces Interleukin-8 Production Clin. Vaccine Immunol., January 1, 2007; 14(1): 94 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Siddiqui, R. J. Shattock, and T. S. Harrison Role of Capsule and Interleukin-6 in Long-Term Immune Control of Cryptococcus neoformans Infection by Specifically Activated Human Peripheral Blood Mononuclear Cells Infect. Immun., September 1, 2006; 74(9): 5302 - 5310. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhou, R. A. Gault, T. R. Kozel, and W. J. Murphy Immunomodulation with CD40 Stimulation and Interleukin-2 Protects Mice from Disseminated Cryptococcosis Infect. Immun., April 1, 2006; 74(4): 2161 - 2168. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bicanic and T. S. Harrison Cryptococcal meningitis Br. Med. Bull., April 18, 2005; 72(1): 99 - 118. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |